Impact of COVID-19 on Orders, Delivery Schedules and Development Operations
First written in FY2020. 4 of 14 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025MitigatedAnnual report
「The impact of COVID-19, regional conflicts including the invasion of Ukraine, China's economic slowdown, the weaker yen and higher prices was minor because of the group's business-sector composition, which is relatively resilient to economic conditions, and its diverse customer base.」
The company explains that the impact of external-environment risks, including COVID-19, was minor during the fiscal year due to its business-sector and customer-base composition. - FY2024MitigatedAnnual report
「The impact of COVID-19, regional conflicts including the invasion of Ukraine, the sluggish overseas economy, yen depreciation and higher prices was limited because of the company's business mix, which is relatively less affected by economic conditions, and its diverse customer base.」
The company explains that the impact of COVID-19 was minor during the fiscal year due to the composition of its business sectors and customer base. - FY2023MitigatedAnnual report
「COVID-19 has been reclassified as a Category 5 disease, but many uncertainties remain, and we will continue to closely monitor developments. The impact of the spread of infection on our business performance has so far been minor, and we have no significant concerns regarding the future.」
The company continues to monitor the uncertainty surrounding the infectious disease, but states that the impact of the spread of infection on performance has been minor to date and that it has no significant concerns going forward. - FY2023-Q3RestatedAnnual report
「There have been no material changes in the impact of COVID-19 described in the additional information to the annual securities report for the previous fiscal year.」
The company is reaffirming that there have been no material changes from its existing risk assessment regarding the impact of COVID-19. - FY2023-Q1RestatedAnnual report
「There have been no material changes in the impact of COVID-19 described in the additional information to the annual securities report for the previous fiscal year.」
The company states that there have been no material changes from its existing risk assessment regarding the impact of COVID-19. - FY2022MitigatedAnnual report
「There remain many uncertainties regarding when COVID-19 will subside and other matters, and we will continue to closely monitor developments. As of now, however, the impact of the spread of infection on our business performance is minor.」
The company continues to monitor the infectious-disease risk itself and the related uncertainty, but explains that the impact on performance was minor as of the end of the fiscal year. - FY2022-Q3RestatedAnnual report
「Demand for embedded development for automotive applications continued to expand steadily, and revenue from development projects using technologies such as autonomous driving, AUTOSAR and model-based development remained firm. Meanwhile, in embedded development for industrial equipment, equipment manufacturers have remained cautious about new product development, product improvements and product development plans since the beginning of the fiscal year, and we will continue to monitor trends in development investment.」
The company is reaffirming the coexistence of recovery and expansion in automotive-related business and caution in industrial equipment-related business with respect to the impact of revised investment plans due to infectious disease. - FY2022-Q2Recovery and expansion in automotive-related business alongside cautious investment in industrial equipmentAnnual report
「Demand for embedded development for automotive applications continued to expand steadily, and revenue from development projects using technologies such as autonomous driving, AUTOSAR and model-based development remained firm. Meanwhile, in embedded development for industrial equipment, equipment manufacturers remained cautious about new product development, product improvements and product development plans.」
While the impact of manufacturers' revised investment plans due to infectious disease continued in the industrial equipment-related business, automotive-related development saw expanding demand and firm revenue. Revenue from the embedded-related business as a whole was ¥1,329.859 million, up 10.8% year on year. - FY2022-Q1Automotive-related business recovered despite continued effects of the pandemicAnnual report
「Although automotive-related development recovered steadily from the previous year, revenue from the embedded-related business was ¥573.918 million, down 2.0% year on year, due to the impact of revised investment plans for new products and technologies by manufacturers resulting from the spread of COVID-19 in both consumer and industrial equipment-related development.」
While manufacturers' revised investment plans in connection with COVID-19 continued to appear as a 2.0% year-on-year decline in embedded-related business revenue, the company explains that automotive-related development recovered. - FY2021MaterialisedAnnual report
「In automotive embedded development, in addition to the recovery in the performance of domestic automakers, progress in the software-first approach advocated by major automakers and the accelerating shift to EVs toward achieving carbon neutrality globally are expected to bring qualitative changes to automotive embedded software development.」
While revisions to customers' investment plans due to the spread of infectious disease appeared in full-year performance as a 1.0% year-on-year decline in embedded-related revenue, the company also describes future demand driven by recovery and the shift to EVs. - FY2021-Q3MaterialisedAnnual report
「Due to the impact of revisions to manufacturers' investment in new products and technologies, as end users, resulting from the spread of COVID-19, revenue from the embedded-related business was ¥1,830.579 million, down 2.7% year on year, in both automotive-related and consumer and industrial equipment-related development.」
The impact of customer revisions to development investment due to COVID-19 also appeared in cumulative third-quarter performance as a 2.7% decline in embedded-related business revenue. - FY2021-Q2MaterialisedAnnual report
「Due to the impact of revisions to manufacturers' investment in new products and technologies, as end users, resulting from the spread of COVID-19, revenue from the embedded-related business was ¥1,200.696 million, down 7.6% year on year, in both automotive-related and consumer and industrial equipment-related development.」
The impact of customer revisions to development investment due to COVID-19 also appeared in actual performance in the second quarter as a 7.6% decline in embedded-related business revenue. - FY2021-Q1MaterialisedAnnual report
「For embedded development for automotive and consumer applications, we aim to expand performance going forward while paying close attention to changes in the order environment, including revisions to major customers' development plans and the status of budget execution, because continued and expanding orders are expected over the medium to long term as COVID-19 subsides.」
The company states that revisions to customers' development plans and budgets in connection with COVID-19 actually appeared as a decline in embedded-related revenue, meaning that the existing infectious-disease risk affected business performance. - FY2020First statedAnnual report
「(1) A decline in orders and revenue resulting from the postponement or cancellation of customers' IT investment and product development plans due to deteriorating performance at our customers; and (2) lost opportunities to win new development orders, as well as delivery delays and problems caused by disruption to development schedules, if infections spread among our employees or partner-company personnel.」
The company discloses as separate risks the postponement or cancellation of customer investment due to the spread of infectious disease, and lost order opportunities and delivery delays resulting from infections among employees and partner-company personnel.